 WALTHAM, Mass., Jan. 05, 2023 GLOBE NEWSWIRE -- Morphic Therapeutic Nasdaq: MORF, a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 2:15 PM PST. 